Form 4: Editas Medicine Executive Sells Shares to Cover Tax Obligations

An Editas Medicine executive, Baisong Mei, sold 541 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Baisong Mei, an Executive Vice President and Chief Medical Officer at Editas Medicine, sold 541 shares of common stock on December 3, 2024.
• The sale was executed at a weighted average price of $2.0772 per share.
• This transaction was not a discretionary trade but was part of a pre-arranged plan to cover tax withholding obligations from vesting restricted stock units.
• The sale was executed in multiple trades at prices ranging from $2.0507 to $2.0783.
• Following the transaction, Mei still beneficially owns 133,354 shares of Editas Medicine common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the biotechnology industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar sales by executives at other firms.
• The sale of 541 shares is relatively small compared to the total holdings of the executive, which is typical for these types of transactions.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders as it is a small transaction by an executive to cover tax obligations.

Key Dates

Keywords

Editas Medicine, insider trading, stock sale, Baisong Mei, tax obligations, restricted stock units, executive, Form 4